-
Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease.
Schneider CA, Ferrannini E, Defronzo R, Schernthaner G, Yates J, Erdmann E.
J Am Soc Nephrol. 2008 Jan; 19(1):182-7. Epub 2007 Dec 5.
[J Am Soc Nephrol. 2008]
-
Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial.
Tonelli M, Jose P, Curhan G, Sacks F, Braunwald E, Pfeffer M, Cholesterol and Recurrent Events (CARE) Trial Investigators.
BMJ. 2006 Jun 17; 332(7555):1426. Epub 2006 May 19.
[BMJ. 2006]
-
ReviewGenetic modification of xenografts.
Platt JL.
Curr Top Microbiol Immunol. 2003; 278:1-21.
[Curr Top Microbiol Immunol. 2003]